New EMA guidance available for Parkinsons and Diabetes, CF endpoint workshop dates announced

In the past few weeks the European Medicines Agency has released updated guidance in a number of disease areas, including Parkinsons and diabetes, and they have published the dates of a workshop to discuss endpoints in development of new drugs … Continue reading